| Vitamin D supplementation and prevention of type 2 diabetes AG Pittas, B Dawson-Hughes, P Sheehan, JH Ware, WC Knowler, ... New England journal of medicine 381 (6), 520-530, 2019 | 724 | 2019 |
| Evaluation of cancer risk in patients with periodontal diseases DC Güven, Ö Dizdar, AC Akman, AE BERKER, E Yekedüz, F Ceylan, ... Turkish journal of medical sciences 49 (3), 826-831, 2019 | 64 | 2019 |
| COVID-19 pandemic: changes in cancer admissions DC Guven, BY Aktas, MS Aksun, E Ucgul, TK Sahin, HC Yildirim, G Guner, ... BMJ supportive & palliative care 14 (e1), e376-e379, 2024 | 38 | 2024 |
| Gut microbiota and cancer immunotherapy: prognostic and therapeutic implications DC Guven, BY Aktas, C Simsek, S Aksoy Future Oncology 16 (9), 497-506, 2020 | 18 | 2020 |
| Cancer incidence in Behçet’s disease DC Guven, EC Bolek, SE Altintop, B Celikten, BY Aktas, S Kiraz, İ Gullu, ... Irish Journal of Medical Science (1971-) 189, 1209-1214, 2020 | 13 | 2020 |
| Exploiting DNA repair defects in breast cancer: from chemotherapy to immunotherapy BY Aktas, G Guner, DC Guven, C Arslan, O Dizdar Expert review of anticancer therapy 19 (7), 589-601, 2019 | 11 | 2019 |
| Results of concurrent radiotherapy and immunotherapy in recurrent and metastatic head and neck cancer: A single-center experience SY Sari, MT Yilmaz, BY Aktas, S Aksoy, I Gullu, M Cengiz, G Ozyigit, ... Oral oncology 124, 105658, 2022 | 10 | 2022 |
| Lower prognostic nutritional index is associated with poorer survival in patients receiving immune checkpoint inhibitors DC Guven, OH Aktepe, H Taban, BY Aktas, G Guner, HC Yildirim, ... Biomarkers in Medicine 15 (13), 1123-1130, 2021 | 9 | 2021 |
| Case of metastatic kaposi sarcoma successfully treated with anti-PD-1 immunotherapy E Cesmeci, DC Guven, BY Aktas, S Aksoy Journal of Oncology Pharmacy Practice 27 (7), 1766-1769, 2021 | 8 | 2021 |
| Successful Treatment of Amyloid A–Type Amyloidosis Due to Behçet Disease With Tocilizumab A Ilbay, A Erden, A Sari, B Armagan, BY Aktas, EC Bolek, U Kalyoncu, ... JCR: Journal of Clinical Rheumatology 25 (4), e43-e45, 2019 | 8 | 2019 |
| Pertuzumab, trastuzumab and taxane-based treatment for visceral organ metastatic, trastuzumab-naive breast cancer: real-life practice outcomes E Esin, B Oksuzoglu, A Bilici, I Cicin, O Kostek, MA Kaplan, S Aksoy, ... Cancer chemotherapy and pharmacology 83, 131-143, 2019 | 7 | 2019 |
| Immunogenicity of two doses of inactive COVID‐19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy DC Guven, FGG Incesu, HC Yildirim, E Erul, E Chalabiyev, BY Aktas, ... International Journal of Cancer 152 (4), 679-685, 2023 | 6 | 2023 |
| Pazopanib-induced chylothorax in a patient with renal cell carcinoma B Koylu, F Tekin, BY Aktas, S Kilickap, D Koksal Anti-Cancer Drugs 33 (1), e555-e557, 2022 | 6 | 2022 |
| Sonographic measurements of rectus femoris muscle thickness strongly predict neutropenia in cancer patients receiving chemotherapy G Güner, L Özçakar, Y Baytar, MR Onur, M Demir, BY Aktaş, OH Aktepe, ... Cancers 16 (5), 1061, 2024 | 5 | 2024 |
| Impact of pharmacist-led educational intervention on pneumococcal vaccination rates in cancer patients: a randomized controlled study N Ozdemir, BY Aktas, A Gulmez, AC Inkaya, A Bayraktar-Ekincioglu, ... Supportive Care in Cancer 31 (3), 194, 2023 | 4 | 2023 |
| 773P Differences between hyperprogressive disease and progressive disease in patients receiving immunotherapy HC Yildirim, DCC Guven, OH Aktepe, F Yilmaz, BY Aktas, G Guner, ... Annals of Oncology 33, S894-S895, 2022 | 4 | 2022 |
| Evaluation of factors predicting pathologic complete response in locally advanced HER2 positive breast cancer treated with neoadjuvant pertuzumab, trastuzumab and chemotherapy … O Ates, OB Oksuzoglu, BY Aktas, I Karadag, S Esen, S Karakaya, D Uncu, ... J. BUON 26, 1398-1404, 2021 | 4 | 2021 |
| Real-life comparison of the afatinib and first-generation tyrosine kinase inhibitors in nonsmall cell lung cancer harboring EGFR exon 19 deletion: a Turk Oncology Group (TOG) study B Bilgin, MAN Sendur, S Yucel, E Celik, DT Ozyukseler, M Ayhan, ... Journal of Cancer Research and Clinical Oncology 147, 2145-2152, 2021 | 4 | 2021 |
| Complete responses to two different anti-PD1 agents in a metastatic melanoma patient S Kilickap, DC Guven, OH Aktepe, BY Aktas, O Dizdar Journal of Oncology Pharmacy Practice 26 (2), 496-499, 2020 | 3 | 2020 |
| Emerging treatment strategies in hepatobiliary cancer DC Guven, HC Yildirim, E Chalabiyev, F Kus, F Yilmaz, S Yasar, ... Expert Review of Anticancer Therapy 23 (3), 243-256, 2023 | 2 | 2023 |
